Carter Gould of Barclays, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $195 to $187 on, Apr 29th, 2024.
Carter has made no other calls on ABBV in the last 4 months.
There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Carter's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Carter
- Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
- Gary Nachman of "Raymond James" Maintained at Buy with Increased Target to $189 on, Tuesday, February 6th, 2024
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $195 on, Tuesday, February 6th, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $200 on, Monday, February 5th, 2024
- Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, January 29th, 2024